← Evidence map

ReviewCells2025

CYR61 as a Potential Biomarker and Target in Cancer Prognosis and Therapies.

Andrew J Schenker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40497940